Home › Compare › SMGI vs MRK

SMGI vs MRK: Dividend Comparison 2026

SMGI yields 153846.15% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SMGI wins by $5966871385817.02M in total portfolio value
10 years
SMGI
SMGI
● Live price
153846.15%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5966871385817.07M
Annual income
$2,583,803,973,102,892,000.00
Full SMGI calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SMGI vs MRK

📍 SMGI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMGIMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMGI + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
SMGI pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMGI
Annual income on $10K today (after 15% tax)
$13,076,923.08/yr
After 10yr DRIP, annual income (after tax)
$2,196,233,377,137,458,200.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SMGI beats the other by $2,196,233,377,137,449,700.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMGI + MRK for your $10,000?

SMGI: 50%MRK: 50%
100% MRK50/50100% SMGI
Portfolio after 10yr
$2983435692908.57M
Annual income
$1,291,901,986,551,451,000.00/yr
Blended yield
43.30%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SMGI
No analyst data
Altman Z
-0.1
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMGI buys
0
MRK buys
0
No recent congressional trades found for SMGI or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMGIMRK
Forward yield153846.15% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7% ✓
Portfolio after 10y$5966871385817.07M ✓$56.8K
Annual income after 10y$2,583,803,973,102,892,000.00 ✓$9,798.13
Total dividends collected$5648820116847.43M ✓$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SMGI vs MRK ($10,000, DRIP)

YearSMGI PortfolioSMGI Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$7,703,008$7,692,307.69$11,206$366.19+$7.69M → SMGI
2$2,777,116,299$2,768,874,080.63$12,650$502.35+$2777.10M → SMGI
3$469,440,923,736$466,469,409,296.58$14,407$694.19+$469440.91M → SMGI
4$37,348,804,612,597$36,846,502,824,198.81$16,585$967.82+$37348804.60M → SMGI
5$1,409,829,769,716,659$1,369,866,548,781,180.20$19,342$1,363.89+$1409829769.70M → SMGI
6$25,671,718,363,996,356$24,163,200,510,399,530.00$22,913$1,947.19+$25671718363.97M → SMGI
7$233,071,501,916,982,500$205,602,763,267,506,370.00$27,662$2,823.89+$233071501916.95M → SMGI
8$1,121,653,440,100,779,400$872,266,933,049,608,100.00$34,159$4,173.35+$1121653440100.75M → SMGI
9$3,161,745,245,527,273,000$1,961,576,064,619,439,000.00$43,337$6,308.80+$3161745245527.23M → SMGI
10$5,966,871,385,817,075,000$2,583,803,973,102,892,000.00$56,776$9,798.13+$5966871385817.02M → SMGI

SMGI vs MRK: Complete Analysis 2026

SMGI — Stock

SMG Industries Inc. operates as a transportation company in the United States. It transports infrastructure components, including bridge beams and power generation transformers; wind energy components; and midstream compressors. The company is also involved in the heavy haul of production equipment, heat exchangers, coolers, construction equipment, and refinery components; transportation of natural gas compressors; flatbed freight; and crane services used to set equipment on compressor stations, pipeline infrastructure, and load drilling rig components. In addition, it offers drilling rig relocation services for drilling contractors and oil and gas operators; and freight brokerage services. The company was formerly known as SMG Indium Resources Ltd. and changed its name to SMG Industries Inc. in April 2018. SMG Industries Inc. was incorporated in 2008 and is headquartered in Houston, Texas.

Full SMGI Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SMGI vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMGI vs SCHDSMGI vs JEPISMGI vs OSMGI vs KOSMGI vs MAINSMGI vs JNJSMGI vs ABBVSMGI vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.